Outcome of Board Meeting

October 29, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza Phiroze Jeejeebhoy Towers B(SaYnMdrBaO KLu:r TlaH CYoRmOpCleAxR, E ) D(SaClaRlI SPt rCeOeDt, E: 539871) Bandra (E), Mumbai - 400051 Mumbai- 400001 Subject: Outcome of the Board Meeting held on Thursday, October 29, 2026 Dear Sir/Madam, “SEBI Pursuant to Regulation 30 and other applicable provisions of the Securities and Exchange Listing Regulations” Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( Thursday, October 29, 2026, ), we wish to inform you that the Board of Directors of the Company (“Board”), at its meeting held today i.e., inter alia, considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2026, along with the Limited Review Reports thereon. Pursuant to Regulation 33(3) of the SEBI Listing Regulations, the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026, Annexure A together with the Limited Review Reports issued by the Statutory Auditors of the Company, are attached herewith as . The aforesaid financial results are also being made available on the Company's website at https://investor.thyrocare.com. The Board Meeting commenced at 2:35 P.M. and concluded at 03:42 P.M. This is for your information and records. Thyrocare Technologies Limited, Yours Faithfully, Brijesh Kumar Encl.: As above Company Secretary and Compliance Officer Annexure-A Price Waterhouse Chartered Accountants LLP Review Report The Board of Directors Thyrocare Technologies Limited D/37-1, TIC Industrial Area, MIDC Turbhe, Navi Mumbai -400 703. 1. We have reviewed the unaudited standalone financial results ofThyrocare Technologies Limited (the "Company") for the quarter ended September 30, 2026 and the year to date results for the period April 01, 2026 to September 30, 2026, and the notes that include the Unaudited Standalone Statement of Assets and Liabilities as on that date and the Unaudited Standalone Statement of Cash Flows for the half-year ended on that date which are included in the accompanying 'Unaudited Standalone Financial Results for the Quarter and Six Months Ended September 30, 2026' (the "Statement"). The Statement has been prepared by the Company pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (the "Listing Regulations, 2015"), which has been initialled by us for identification purposes. 2. This Statement, which is the responsibility of the Company's Management and approved by the Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 "Interim Financial Reporting" ("Ind AS 34"), prescribed under Section 133 of the Companies Act, 2013, and other accounting principles generally accepted in India. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410 "Review of Interim Financial Information Performed by the Independent Auditor of the Entity", issued by the Institute of Chartered Accountants of India. This Standard requires that we plan and perform the review to obtain moderate assurance as to whether the Statement is free of material misstatement. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. C'. ,- 127" , Price Waterhouse Chartered Accountants LLP, 252, Veer Savarkar Marg, Shivaji Park, Dadar (West), Mumbai-400 028 T: +91(22) 66697510 Registered office and Head office: 11-A, Vishnu Digamber Marg, Sucheta Bhawan, New Delhi -110 002 Price Waterhouse (a Partnership Finn) converted into Price Waterhouse Chartered Accountants LLP (a Limited Liability Partnership with LLP identity no: LLPIN AAC-5001) with effect from July 25, 2014. Post its Conversion to Price Waterhouse Chartered Accountants LLP its !CAI registration number is 012754N/N500016 (!CAI registration number before conversion was 012754N) Price Waterhouse Chartered Accountants LLP The Board of Directors Thyrocare Technologies Limited Page2 of 2 4. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the Statement has not been prepared in all material respects in accordance with the recognition and measurement principles laid down in the aforesaid Indian Accounting Standard and other accounting principles generally accepted in India and has not disclosed the information required to be disclosed in terms of Regulation 33 of the Listing Regulations, 2015 including the manner in which it is to be disclosed, or that it contains any material misstatement. 5. (a) The standalone financial results of the Company for the quarter ended September 30, 2025 and the year to date results for the period April 01, 2025 to September 30, 2025 were reviewed by another firm of chartered accountants who, vide their report dated October 14, 2025, expressed an unmodified conclusion on those financial results. (b) The standalone financial statements of the Company for the year ended March 31, 2026 were audited by another firm of Chartered Accountants, who issued an unmodified opinion vide their report dated May 07, 2026. • Our conclusion is not modified in respect of these matters. For Price Waterhouse Chartered Accountants LLP Firm Registration Number: 012754N/N500016 Nitin Khatri Partner Membership Number: 110282 UDIN: 26110282KNJSHG9091 Place: Mumbai Date: October 29, 2026 THYROCARE TECHNOLOGIES LIMITED Registered Office: D/37-1, TIC Industrial Area, MIDC Turbhe, Navi Mumbai 400 703 Corporate Office: D/37-3, TTC Industrial Area, MIDC Turbhe, Navi Mumbai 400 703 Tel: (91 22) 2762 2762 I Fax: (91 22) 2768 2409 Website: www.thyroc8Ie.com E-mail: compliance@thyrocare.com Corporate Identity Number: L86905MH2000PLC123882 Unaudited Standalone Financial Results for the Quarter and Six Months Ended September 30, 2026 (Rs. in Crores) Quarter ended Six Month Ended March 31, Sr.No Particulars September June 30, September September September 2026 30,2026 2026 30,2025 30,2026 30,2025 (Audited) (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Unaudited) 1 Revenue (a) Revenue from operations 256.25 225.66 202.23 481.91 381.12 774.27 (b) Other Income 2.94 3.51 2.28 6.45 6.24 13.39 Total Reveue (a+b) 259.19 229.17 204.51 488.36 387.36 787.66 2 Expenses (a) Cost of materials consumed 67.19 58.86 57.12 126.05 109.49 208.37 (b) Purchase of stock-in-trade 0.33 0.03 0.21 0.36 0.28 1.09 (c) Changes in inventories of finished goods, work-in-progress 0.25 0.24 0.04 0.49 0.19 (0.23) and stock-in-trade (d) Employee benefits expense 43.24 37.16 31.37 80.40 62.07 128.29 (e) Finance cost 1.48 1.26 0.60 2.74 1.22 2.18 (f) Depreciation and amortisation expense 12.50 11.23 9.70 23.73 18.65 51.17 (g) Other expenses 59.20 53.76 44.58 112.96 83.66 180.42 Total Expenses 184.19 162.54 143.62 346.73 275.56 571.29 3 Profit before exceptional items and income tax (1 -2) 75.00 66.63 60.89 141.63 111.80 216.37 4 Exceptional Items (Refer note 4 below) (9.17) - - (9.17) - (5.97) 5 Profit after exceptional items and before tax (3 + 4) 65.83 66.63 60.89 132.46 111.80 210.40 6 Tax expense (17.70) (16.46) (17.86) (34.16) (32.72) (61.59) 7 Profit for the period/year (5 + 6) 48.13 50.17 43.03 98.30 79.08 148.81 8 Other comprehensive income Items that will not be reclassified to profit or loss (net of tax) (0.63) 0.48 [Showing first 8,000 characters — download PDF for full document]